Sotera Health Company (NASDAQ:SHC) Receives $17.80 Consensus PT from Brokerages

Shares of Sotera Health Company (NASDAQ:SHC) have earned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $17.80.

Several analysts have recently commented on SHC shares. Barclays raised their price objective on shares of Sotera Health from $19.00 to $20.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. William Blair began coverage on shares of Sotera Health in a report on Thursday, December 18th. They issued an “outperform” rating for the company. BMO Capital Markets started coverage on shares of Sotera Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $19.00 price target for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a research report on Monday. Finally, Piper Sandler boosted their target price on Sotera Health from $15.00 to $17.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $17.75 on Wednesday. The business has a 50-day moving average price of $16.70 and a two-hundred day moving average price of $14.97. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.83. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04. The company has a market cap of $5.04 billion, a P/E ratio of 93.43 and a beta of 1.81.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, November 4th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.22 by $0.04. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.The company had revenue of $311.31 million for the quarter, compared to analyst estimates of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. As a group, analysts anticipate that Sotera Health will post 0.61 EPS for the current year.

Insider Transactions at Sotera Health

In related news, Director Pincus & Co. Warburg sold 9,720,000 shares of the stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the completion of the transaction, the director owned 34,102,952 shares in the company, valued at approximately $556,901,206.16. This represents a 22.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the sale, the director owned 22,735,301 shares of the company’s stock, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 29,384,104 shares of company stock valued at $471,824,511 over the last three months. Corporate insiders own 55.12% of the company’s stock.

Institutional Trading of Sotera Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its position in shares of Sotera Health by 10.4% during the first quarter. Invesco Ltd. now owns 306,398 shares of the company’s stock valued at $3,573,000 after buying an additional 28,892 shares during the period. Nuveen LLC bought a new stake in Sotera Health during the 1st quarter worth approximately $4,433,000. AlphaQuest LLC purchased a new stake in Sotera Health in the 1st quarter worth approximately $538,000. Campbell & CO Investment Adviser LLC lifted its stake in Sotera Health by 21.4% in the 1st quarter. Campbell & CO Investment Adviser LLC now owns 114,250 shares of the company’s stock worth $1,332,000 after purchasing an additional 20,142 shares in the last quarter. Finally, State of Wyoming boosted its holdings in Sotera Health by 284.9% in the 1st quarter. State of Wyoming now owns 12,695 shares of the company’s stock valued at $148,000 after purchasing an additional 9,397 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.